Testing effectiveness (Phase 2)Ended earlyNCT01972438
What this trial is testing
A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients
Who this might be right for
Graft vs Host Disease
National Eye Institute (NEI) 18